The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/35892
StudyName: Eligibility Head and Neck Squamous Cell Carcinoma (HNSCC) NCT02255097
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 02.04.2019
License: Creative Commons BY 4.0

----

Description: 
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055); ODM derived from: https://clinicaltrials.gov/show/NCT02255097
